Concepedia

Author

P Salvato

Diversified Technical Systems (United States)

Also Known As

Marco Zahedi, P D Salvato, P Salvato, P. D. Salvato, P. Salvato, P.D. Salvato

11

Publications

221

Citations

5

H-Index

11

Concepts

All Affiliations

Diversified Technical Systems (United States)Research Triangle Park Foundation
PS

About

P Salvato is an author at Diversified Technical Systems (United States) specializing in pharmacotherapy, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

144

2

Pharmacology

2

2

144

3

Allergy

1

1

55

4

Epidemiology

1

1

43

5

Immunology

1

1

55

P Salvato

×

5

Publications

214

Citations

5

H-Index

YearCitations

Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:PolyC12U in the treatment of HIV infection

Kenneth Thompson, David R. Strayer, P Salvato,

European Journal of Clinical Microbiology & Infectious Diseases

1996

89

Changes in the 2-5A synthetase/RNase L antiviral pathway in a controlled clinical trial with poly(I)-poly(C12U) in chronic fatigue syndrome.

Robert J. Suhadolnik, N L Reichenbach, Patricia Hitzges,

PubMed

1995

55

‘Lyme disease’: ancient engine of an unrecognized borreliosis pandemic?

William T. Harvey, P Salvato

Medical Hypotheses

2003

43

Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV‐infected, therapy‐naïve patients: results of the EPIC study (CCR100136)<sup>*</sup>

P. Yéni, Anthony LaMarca, Daniel Berger,

HIV Medicine

2009

15

Thymidine-analog and multi-nucleoside resistance mutations are observed in both zidovudine-naive and zidovudine-experienced subjects with viremia after treatment with stavudine-containing regimens.

Lisa Ross, Kenneth R. Henry, Dávid Paár,

PubMed

2002

12

Page 1